Abstract:Recent work suggests that extracellular (cell-free) nucleic acids, both DNA and RNA species, as well as extracellular nucleosomes can activate blood coagulation and promote thrombosis in vitro and in vivo (1, 2). Indeed, they substantially contribute to the development of microvascular thrombosis which can act as an intravascular immune response to circulating bacteria and has been termed immunothrombosis (3). However, they also foster pathological vessel occlusions as shown in animal models of large vessel thrombosis including deep-vein thrombosis and arterial thrombosis. Large filaments of extracellular nucleosomes that are released from activated neutrophils (neutrophil extracellular traps, NETs) and isolated extracellular nucleosomes support fibrin formation and platelet adhesion/activation via different mechanisms. These include for example stimulation of fibrin formation by degradation of the endogenous anticoagulant tissue factor pathway inhibitor and via activation of proteins involved in the contact pathway of blood coagulation such as factor XII (2, 3). The study by Varju et al. (4) adds a new aspect to the procoagulant role of nucleosome components and NETs. These authors show that isolated eukaryotic DNA and histone proteins such as HIIIS enhance the diameter of thrombus-forming fibrin fibers under in vitro conditions. Moreover, they are found to decrease the permeability of fibrin clots and to enhance the overall stability of such clots. Mechanistically, these effects are mediated by regulation of endogenous anticoagulant and fibrinolytic pathways. Indeed, histone proteins prevented the inactivation of thrombin by antithrombin and DNA reduced plasminogen activation. Furthermore, NETs released from isolated neutrophils suppressed t-PA-promoted fibrinolysis. Together with earlier work, these results further corroborate the conclusion that extracellular nucleosomes and their major components target the coagulation system at different levels and that their overall effect is to enhance fibrin formation. It will be of interest to clarify in the future whether the stabilization of fibrin clots by histones, DNA and nucleosomes as shown in (4) contributes to the prothrombotic role of NETs and extracellular nucleosomes in vivo.

A novel role of acellular hemoglobin in hemolytic thrombosis

Inhibition of Hb Binding to GP1bα Abrogates Hb-Mediated Thrombus Formation on Immobilized VWF and Collagen under Physiological Shear Stress

Distinct platelet interactions with soluble and immobilized von Willebrand factor modulate platelet adhesion and aggregation with differential impact on hemostasis and thrombosis

Novel functions for Von Willebrand factor

Influence of Hematocrit Level and Integrin αIIbβIII Function on vWF-Mediated Platelet Adhesion and Shear-Induced Platelet Aggregation in a Sudden Expansion

Molecular Basis of the Initial Platelet Adhesion in Arterial Thrombosis: Molecular Dynamics Simulations.

A Mechanism for Localized Dynamics-driven Affinity Regulation of the Binding of Von Willebrand Factor to Platelet Glycoprotein Ibα*

Extracellular DNA and histones as thrombus stabiliser

Extracellular DNA and histones: double‐edged swords in immunothrombosis

Viral Infection Related Venous Thromboembolism: Potential Mechanism and Therapeutic Targets.

In Vivo Relevance for Platelet Glycoprotein Ibα Residue Tyr276 in Thrombus Formation.

HMGB1: a Novel Protein That Induced Platelets Active and Aggregation Via Toll-like Receptor-4, NF-κB and Cgmp Dependent Mechanisms.

Conformation-dependent blockage of activated VWF improves outcomes of traumatic brain injury in mice

Hemin regulates platelet clearance in hemolytic disease by binding to GPIbα

Exploring ligands that target von Willebrand factor selectively under oxidizing conditions through docking and molecular dynamics simulations

Emerging Role of High Mobility Group Box-1 in Thrombosis-Related Diseases

The Co-Influence of VWD Type 2B/2M Mutations in the A1 Domain and Platelet GPIbα on the Rate of Cleavage to VWF by ADAMTS13

Removal of the vicinal disulfide enhances the platelet-capturing function of von Willebrand factor

Defective Association of the Platelet Glycoprotein Ib–IX Complex with the Glycosphingolipid-Enriched Membrane Domain Inhibits Murine Thrombus and Atheroma Formation

Synergic Effect Of Gpiba And Von Willebrand Factor In Pathogenesis Of Deep Vein Thrombosis

A recombinant fragment of von Willebrand factor reduces fibrin-rich microthrombi formation in mice with endotoxemia